Innoviva Accounts Payable vs Cash And Short Term Investments Analysis

INVA Stock  USD 19.05  0.09  0.47%   
Innoviva financial indicator trend analysis is infinitely more than just investigating Innoviva recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innoviva is a good investment. Please check the relationship between Innoviva Accounts Payable and its Cash And Short Term Investments accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.

Accounts Payable vs Cash And Short Term Investments

Accounts Payable vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innoviva Accounts Payable account and Cash And Short Term Investments. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Innoviva's Accounts Payable and Cash And Short Term Investments is 0.44. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Innoviva, assuming nothing else is changed. The correlation between historical values of Innoviva's Accounts Payable and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Innoviva are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Accounts Payable i.e., Innoviva's Accounts Payable and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

0.44
Relationship DirectionPositive 
Relationship StrengthWeak

Accounts Payable

An accounting item on the balance sheet that represents Innoviva obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Innoviva are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Innoviva balance sheet. This account contains Innoviva investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Innoviva fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.
Most indicators from Innoviva's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innoviva current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.At present, Innoviva's Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Over EBITDA is expected to grow to 5.50, whereas Discontinued Operations is forecasted to decline to (89.7 M).

Innoviva fundamental ratios Correlations

0.840.710.390.09-0.190.180.130.160.030.34-0.36-0.05-0.120.290.680.97-0.180.090.270.68-0.050.860.020.26-0.36
0.840.860.46-0.3-0.37-0.37-0.410.260.230.340.080.12-0.620.420.580.78-0.57-0.440.330.51-0.380.81-0.450.220.08
0.710.860.46-0.58-0.77-0.36-0.37-0.050.080.440.20.0-0.540.260.470.72-0.44-0.42-0.060.49-0.710.64-0.220.080.2
0.390.460.460.04-0.33-0.21-0.07-0.41-0.49-0.09-0.3-0.3-0.27-0.480.490.43-0.24-0.09-0.210.74-0.220.33-0.150.66-0.3
0.09-0.3-0.580.040.770.70.7-0.07-0.39-0.25-0.86-0.250.65-0.290.130.080.510.730.110.330.92-0.060.360.4-0.86
-0.19-0.37-0.77-0.330.770.330.280.320.04-0.32-0.40.110.350.08-0.19-0.260.20.340.43-0.180.92-0.14-0.040.11-0.4
0.18-0.37-0.36-0.210.70.330.97-0.11-0.28-0.03-0.72-0.280.92-0.240.140.230.760.97-0.10.180.6-0.030.870.05-0.72
0.13-0.41-0.37-0.070.70.280.97-0.23-0.42-0.2-0.75-0.420.93-0.450.210.180.810.99-0.170.230.56-0.120.910.14-0.75
0.160.26-0.05-0.41-0.070.32-0.11-0.230.910.190.40.47-0.250.680.06-0.01-0.39-0.250.78-0.410.090.32-0.32-0.320.4
0.030.230.08-0.49-0.390.04-0.28-0.420.910.30.680.55-0.380.79-0.1-0.11-0.47-0.440.6-0.56-0.20.24-0.35-0.470.68
0.340.340.44-0.09-0.25-0.32-0.03-0.20.190.30.150.49-0.230.450.090.34-0.42-0.230.060.09-0.330.55-0.15-0.340.15
-0.360.080.2-0.3-0.86-0.4-0.72-0.750.40.680.150.44-0.640.45-0.31-0.41-0.57-0.780.15-0.67-0.67-0.12-0.49-0.471.0
-0.050.120.0-0.3-0.250.11-0.28-0.420.470.550.490.44-0.40.5-0.07-0.13-0.46-0.410.45-0.47-0.060.18-0.41-0.090.44
-0.12-0.62-0.54-0.270.650.350.920.93-0.25-0.38-0.23-0.64-0.4-0.4-0.16-0.030.850.95-0.330.040.59-0.30.88-0.03-0.64
0.290.420.26-0.48-0.290.08-0.24-0.450.680.790.450.450.5-0.4-0.130.21-0.5-0.450.44-0.29-0.070.46-0.43-0.410.45
0.680.580.470.490.13-0.190.140.210.06-0.10.09-0.31-0.07-0.16-0.130.59-0.090.150.420.51-0.070.490.090.43-0.31
0.970.780.720.430.08-0.260.230.18-0.01-0.110.34-0.41-0.13-0.030.210.59-0.10.150.050.73-0.070.830.110.26-0.41
-0.18-0.57-0.44-0.240.510.20.760.81-0.39-0.47-0.42-0.57-0.460.85-0.5-0.09-0.10.82-0.330.050.46-0.540.820.17-0.57
0.09-0.44-0.42-0.090.730.340.970.99-0.25-0.44-0.23-0.78-0.410.95-0.450.150.150.82-0.180.220.61-0.140.890.14-0.78
0.270.33-0.06-0.210.110.43-0.1-0.170.780.60.060.150.45-0.330.440.420.05-0.33-0.18-0.220.240.33-0.34-0.030.15
0.680.510.490.740.33-0.180.180.23-0.41-0.560.09-0.67-0.470.04-0.290.510.730.050.22-0.220.040.480.080.53-0.67
-0.05-0.38-0.71-0.220.920.920.60.560.09-0.2-0.33-0.67-0.060.59-0.07-0.07-0.070.460.610.240.04-0.130.250.26-0.67
0.860.810.640.33-0.06-0.14-0.03-0.120.320.240.55-0.120.18-0.30.460.490.83-0.54-0.140.330.48-0.13-0.22-0.04-0.12
0.02-0.45-0.22-0.150.36-0.040.870.91-0.32-0.35-0.15-0.49-0.410.88-0.430.090.110.820.89-0.340.080.25-0.22-0.02-0.49
0.260.220.080.660.40.110.050.14-0.32-0.47-0.34-0.47-0.09-0.03-0.410.430.260.170.14-0.030.530.26-0.04-0.02-0.47
-0.360.080.2-0.3-0.86-0.4-0.72-0.750.40.680.151.00.44-0.640.45-0.31-0.41-0.57-0.780.15-0.67-0.67-0.12-0.49-0.47
Click cells to compare fundamentals

Innoviva Account Relationship Matchups

Innoviva fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets724.8M999.6M926.4M1.2B1.2B1.3B
Total Stockholder Equity313.5M539.9M414.7M565.8M675.0M708.7M
Retained Earnings(946.4M)(722.0M)(456.1M)(204.9M)(25.2M)(26.4M)
Other Assets293.6M657.5M425.2M198.5M228.2M131.6M
Common Stock Shares Outstanding113.4M113.6M94.3M95.2M86.9M81.9M
Liabilities And Stockholders Equity724.8M999.6M926.4M1.2B1.2B1.3B
Other Stockholder Equity1.3B1.3B870.2M770.0M699.5M1.0B
Total Liab382.7M391.7M400.5M665.7M568.6M442.4M
Short Long Term Debt Total377.1M410.5M394.7M637.9M449.1M332.2M
Other Current Liab5.4M6.0M5.7M31.7M17.2M12.9M
Total Current Liabilities5.4M6.1M5.8M38.8M38.1M25.0M
Other Liab586K219K106K84.2M75.8M49.3M
Property Plant And Equipment Net33K28K12K3.4M3.0M2.9M
Net Debt99.0M139.0M193.1M346.8M255.6M192.9M
Accounts Payable10K66K27K2.9M6.7M7.1M
Cash278.1M246.5M201.5M291.0M193.5M138.1M
Non Current Assets Total293.6M657.5M612.7M788.0M899.3M944.3M
Non Currrent Assets Other139.4M214K108K101.9M87.1M68.4M
Long Term Debt377.1M385.5M394.7M540.4M446.2M321.7M
Cash And Short Term Investments350.8M246.5M201.5M291.0M193.5M235.5M
Net Receivables79.4M93.9M110.7M64.1M84.1M88.3M
Common Stock Total Equity1.0M1.0M1.0M696K800.4K857.6K
Short Term Investments72.7M438.3M483.8M403.0M463.5M486.6M
Non Current Liabilities Total377.3M385.6M394.7M626.9M530.4M426.9M
Other Current Assets80.4M95.6M1.4M32.5M25.9M22.6M
Property Plant And Equipment Gross33K28K12K3.4M3.0M2.9M
Total Current Assets431.2M342.1M313.7M443.5M344.2M281.5M
Common Stock1.0M1.0M696K692K633K845.9K
Property Plant Equipment33K28K12K3.4M3.1M2.9M
Inventory(79.4M)(93.9M)(110.7M)55.9M40.7M42.8M
Net Tangible Assets313.5M539.9M414.7M286.2M329.1M345.5M
Noncontrolling Interest In Consolidated Entity152K5.5M67.9M111.2M127.9M134.3M
Retained Earnings Total Equity(1.5B)(1.1B)(722.0M)(456.1M)(524.6M)(550.8M)
Long Term Debt Total574.4M382.9M377.1M385.5M443.3M463.7M
Capital Surpluse1.3B1.3B1.3B1.3B1.1B1.1B
Deferred Long Term Liab139.1M125.3M111.4M97.6M112.2M122.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Innoviva offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innoviva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innoviva Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innoviva Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innoviva. If investors know Innoviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innoviva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.98)
Earnings Share
0.8
Revenue Per Share
5.6
Quarterly Revenue Growth
0.331
Return On Assets
0.0937
The market value of Innoviva is measured differently than its book value, which is the value of Innoviva that is recorded on the company's balance sheet. Investors also form their own opinion of Innoviva's value that differs from its market value or its book value, called intrinsic value, which is Innoviva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innoviva's market value can be influenced by many factors that don't directly affect Innoviva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innoviva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innoviva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innoviva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.